Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep:224:115-123.e2.
doi: 10.1016/j.jpeds.2020.05.028. Epub 2020 May 22.

Fetal Growth Restriction and Hypertension in the Offspring: Mechanistic Links and Therapeutic Directions

Affiliations
Review

Fetal Growth Restriction and Hypertension in the Offspring: Mechanistic Links and Therapeutic Directions

Arvind Sehgal et al. J Pediatr. 2020 Sep.
No abstract available

Keywords: ACE2; angiotensin-(1-7); cardiovascular disease; developmental origins of health and disease; fetal growth restriction; programming; renin-angiotensin system; vascular ageing.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Mechanisms involved in increased arterial thickness and stiffness (central role of the RAS). ACE2, angiotensin-converting enzyme 2; Ang-(1–7), angiotensin-(1–7); AT1R, angiotensin II type 1 receptor; MasR, Mas receptor; NO, nitric oxide; TGF, transforming growth factor.
Figure 2.
Figure 2.
There is no change in blood flow to the brain or heart but an increase in blood flow to the adrenal glands in the chronically hypoxemic intrauterine growth restriction (IUGR) (black bars) compared with the control (white bars) fetus, A. However, there is a decrease in oxygen and glucose delivery to the heart of the IUGR fetus compared with controls, B and C.
Figure 3.
Figure 3.
Summary of therapeutic constructs. Ang, angiotensin; SNS, sympathetic nervous system; PNS, parasympathetic nervous system.

Comment in

  • Fetal growth restriction, nutrition, and the renin-angiotensin system.
    Arisaka O, Ichikawa G, Koyama S, Sairenchi T. Arisaka O, et al. J Pediatr. 2021 Mar;230:274-275. doi: 10.1016/j.jpeds.2020.11.044. Epub 2020 Nov 26. J Pediatr. 2021. PMID: 33249007 No abstract available.
  • Reply.
    South AM, Alexander BT, Morrison JL, Sehgal A. South AM, et al. J Pediatr. 2021 Mar;230:275-276. doi: 10.1016/j.jpeds.2020.11.051. Epub 2020 Nov 27. J Pediatr. 2021. PMID: 33253734 No abstract available.

References

    1. Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT, et al. Potential US population impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation 2018;137:109. - PMC - PubMed
    1. Benjamin EJ, Virani SS, Callaway CW, Chang AR, Cheng S, Chiuve SE, et al. Heart disease and stroke statistics-2018 Update: a report from the American Heart Association. Circulation 2018;137:e67–492. - PubMed
    1. Lees C, Marlow N, Arabin B, Bilardo CM, Brezinka C, Derks JB, et al. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol 2013;42: 400–8. - PubMed
    1. Battaglia FC, Lubchenco LO. A practical classification of newborn infants by weight and gestational age. J Pediatr 1967;71:159–63. - PubMed
    1. Nardozza LMM, Caetano ACR, Zamarian ACP, Mazzola JB, Silva CP, Marçal VMG, et al. Fetal growth restriction: current knowledge. Arch Gynecol Obstet 2017;295:1061–77. - PubMed

Publication types

MeSH terms